Abstract: The present invention relates to a composition comprising a natural complex extract. It is confirmed that the composition has synergistic effects on antioxidant activity, immune enhancement, whitening, anti-wrinkle and collagenase inhibition with low cytotoxicity, and therefore, the composition is suitable for uses of antioxidation, immune, whitening and skin anti-wrinkle.
Type:
Grant
Filed:
January 10, 2018
Date of Patent:
June 16, 2020
Assignees:
COSMAX NS, INC., COSMAX NBT, INC.
Inventors:
Jin Hak Kim, Kwang Soo Baek, Yong Jun Jo, Hyeon Yeong Ahn, Young Min Park, Hyun Ji Kim, Jae Seok Shim, Su Young Choi, Jin Woo Lee, Sang Woo Kim, Mann-Seok Yoon, Jin Hyouk Kwon
Abstract: A hydrogel polymer includes a ceragenin compound. The ceragenin compound has a hydrophobicity/hydrophilicity that produces a release rate in a range of 0.1-100 ?g/ml for at least 3 days.
Abstract: The present invention relates to a method for preparing a medical material for replacing a hard tissue defect and a medical material produced therefrom. More specifically, in the present invention, powders of bioactive glass are press-molded, and are then subjected to a first heat treatment at a relatively low temperature below the glass transition temperature of bioactive glass. Then, the resultant is processed into a desired shape and then subjected to a second heat treatment at a temperature higher than the glass transition temperature of bioactive glass. Accordingly, the present invention provides a medical material which can be customized to a desired shape of a hard tissue defect in a living body and minimize thermal shock, and which is capable of exhibiting a bone fusion property, while overcoming the low compressive strength drawback of hydroxyapatite, which is an existing hard tissue replacement material currently in use.
Type:
Grant
Filed:
August 19, 2016
Date of Patent:
June 2, 2020
Assignee:
Bioalpha Corporation
Inventors:
Mi Young Ryu, Sung Nam Park, Jun Hyuk Seo, Hyun Seung Ryu
Abstract: There is provided a solid pharmaceutical composition formulation for nasal delivery of an opioid antagonist. The pharmaceutical composition includes a pharmacologically-effective amount of an opioid antagonist and a pharmaceutically-acceptable carrier. The pharmaceutical composition is preferably in the form of a powder produced by spray-drying, which is subsequently loaded into single use nasal applicators. Preferred pharmaceutically-acceptable carriers include disaccharides (e.g. lactose or trehalose) and dextrins (e.g. cyclodextrins or maltodextrins), preferably spray-dried together in combination. The pharmaceutical composition may further comprise an alkyl saccharide, preferably a sucrose ester, such as sucrose monolaurate. The compositions and applicators may be employed in the treatment of opioid overdose in subjects.
Type:
Grant
Filed:
July 9, 2019
Date of Patent:
May 19, 2020
Assignee:
OREXO AB
Inventors:
Jonas Sävmarker, Robert Rönn, Andreas Fischer
Abstract: A bioresorbable haemostatic foam sponge for adhering to a wound. The sponge has a tissue-contacting surface divided into a plurality of closely-spaced tissue contacting elements. Also disclosed are methods for forming the haemostatic sponge and methods of using the sponge.
Abstract: The present invention relates to a formulation for the controlled release of active ingredients after the passage of the ileo-cecal-valve, comprising one or more active ingredients or one or more active ingredient containing cores (W), enveloped by one or more envelopments (C), which are dissoluble or permeable above an individual defined pH value and are dissoluble or permeable below another individual defined pH value, again enveloped by an envelopment (E), which is dissoluble or permeable above still another individual defined pH value.
Abstract: Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/soluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.
Type:
Grant
Filed:
November 7, 2018
Date of Patent:
May 12, 2020
Assignee:
PLx Opco Inc.
Inventors:
Upendra K. Marathi, Susann Edler Childress, Shaun L. Gammill, Robert W. Strozier
Abstract: The present invention generally relates to a modified hyaluronic acid (HA) and to a method for making same, more specifically to a (poly)glycerol-modified HA derivative prepared by grafting glycidol to HA. The present invention also relates to the use of the HA derivative for preparing a dermal filler composition, a hydrogel comprising cross-linked HA and the (poly)glycerol-modified HA derivative, and a method for preparing said hydrogel. Furthermore, the present invention relates to the use of the hydrogel as a cosmetic and/or aesthetic product, in particular as a dermal filler for tissue filling, replacing and/or augmenting.
Type:
Grant
Filed:
March 21, 2017
Date of Patent:
May 5, 2020
Assignee:
Merz Pharma GmbH & Co. KGaA
Inventors:
Andreas Krause, Alexander Linko, Franck Villain
Abstract: The present invention is directed to a unique technology for preparing a growth-factor free, cylindrical, hydrogel implant that has multiple (three or more) longitudinal hydrogel zones with varying chemical and physical properties. The implant may be wholly made of hydrogels or the hydrogels may be associated with cells, such as mesenchymal stem cells (MSCs).
Type:
Grant
Filed:
September 3, 2016
Date of Patent:
April 21, 2020
Assignee:
The Texas A&M University System
Inventors:
Melissa A. Grunlan, Mariah S. Hahn, William B. Saunders
Abstract: The present invention relates to a composite powder of jade powder and a porous polymer, and more specifically relates to a composite powder (jade sphere) in which jade powder particles are impregnated in a porous polymer, the composite powder being produced by spraying, in one step, a dispersion in which jade powder has been dispersed in a solution that dissolves porous polymers, and to a cosmetic composition containing the composite powder, and to a manufacturing method for the composite powder.
Type:
Grant
Filed:
February 8, 2019
Date of Patent:
April 21, 2020
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Hyun Suk Lee, Dong-Hyun Paik, Ga Young Cho, Hyoung June Kim, Hae Jin Jung, Dong Hyuk Jang, Yong Jin Kim, Lee Kyoung Kwon, John Hwan Lee, Sung-Wook Choi
Abstract: The present invention relates to a composition for a hydrogel sheet including a cellulose ether, a gelling agent, and a gelling promoter, a hydrogel sheet prepared therefrom, and a method of preparing the hydrogel sheet. According to the present invention, the composition for a hydrogel sheet can be used to prepare a hydrogel sheet capable of maintaining the shape thereof without a support by limiting a type of the gelling agent and/or a viscosity of the cellulose ether included in the composition.
Type:
Grant
Filed:
September 23, 2016
Date of Patent:
April 14, 2020
Assignee:
LOTTE FINE CHEMICAL CO., LTD.
Inventors:
Ju Hee Shin, Ji Seon Jeong, Sung Hwan Bang, Ju Young Jung
Abstract: Described herein are methods of cleaning a tooth comprising administering a composition comprising a zinc amino acid halide complex to the oral cavity; and retaining the composition in the oral cavity for a time sufficient to form a precipitate.
Type:
Grant
Filed:
May 14, 2018
Date of Patent:
April 7, 2020
Assignee:
Colgate-Palmolive Company
Inventors:
Zhiqiang Liu, Long Pan, Shaotang Yuan, Jairajh Mattai, James Masters
Abstract: The present invention relates to the field of coating pharmaceutical substrates. In particular, the invention relates to methods of coating of pharmaceutical substances, pharmaceutical ingredients or a blend of them. The invention also provides a method of making a pharmaceutical formulation which may be processed into a pharmaceutical dosage form, which utilizes solid pharmaceutical particles and a pharmaceutical formulation obtained by the method. The methods of the invention utilize atomic layer deposition technology. The novel methods allow difficult, moisture sensitive and electrically charged pharmaceutical substrates to be easily processable.
Type:
Grant
Filed:
September 26, 2016
Date of Patent:
March 31, 2020
Assignee:
Applied Materials, Inc.
Inventors:
Pekka Hoppu, Tommi Kaariainen, Marja-Leena Kaariainen, Aimo Turunen
Abstract: Liquid nutritional compositions that include functional ingredients such as beta-hydroxy-beta-methylbutyrate, docosahexaenoic acid, and lutein are disclosed. The nutritional compositions are useful to promote at least one of physical performance (e.g., body composition, muscle mass, muscle strength) and cognitive function (e.g., focus, attention, alertness, executive function) in an individual. The functional ingredients are incorporated into the nutritional composition in such a way that they do not adversely affect the desirable properties of the nutritional composition such as, for example, nutritional value, stability, solubility, taste, and mouthfeel.
Abstract: Provided are a transdermal absorption sheet capable of achieving control of the dissolution rate and suppression of diffusion of a drug, and a method of producing the same. A transdermal absorption sheet includes a sheet portion, and a plurality of needle-like protruding portions formed by a plurality of frustum portions arranged on the sheet portion and needle portions arranged on the frustum portions, in which at least one of the needle-like protruding portions has a cavity portion extending from the sheet portion to the frustum portion.
Abstract: A polymer nanofiber scaffold includes a plurality of melt extruded nanofibers that are chemically modified to append surface functionality to the nanofibers.
Abstract: A polymer nanofiber scaffold includes a plurality of melt extruded nanofibers that are chemically modified to append surface functionality to the nanofibers.
Type:
Grant
Filed:
July 3, 2018
Date of Patent:
March 3, 2020
Assignee:
CASE WESTERN RESERVE UNIVERSITY
Inventors:
Jonathan K Pokorski, Eric Baer, Sieun Kim, Jia Wang
Abstract: The present invention relates to biomaterials coated with an active agent eluting coating, wherein implantation of the coated biomaterial results in reduced implant-related complications and/or improved integration of the biomaterial into the host tissue and further relates to kits containing the coated biomaterial. The present invention also relates to methods and kits for coating the biomaterial. It is based, at least in part, on the discovery that biomaterial coated with a cytokine eluting coating resulted in the shift of early stage macrophage polarization that were associated with positive long-term effects such as minimized capsule formation and improved tissue quality and composition as compared to uncoated biomaterials.
Type:
Grant
Filed:
March 15, 2017
Date of Patent:
March 3, 2020
Assignee:
UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Inventors:
Bryan Nicklaus Brown, Daniel Jordi Hachim Diaz
Abstract: Systems, methods, and apparatuses for generating and releasing iodine are described. Some embodiments may include a dressing member including a plurality of iodine-forming reagents and a water-swellable material. In some embodiments, the dressing member may include water-swellable fibers. The water-swellable fibers may each include a water-swellable material in which iodine-forming reagents are dispersed. As liquid comes into contact with and is absorbed by the water-swellable material, the iodine-forming reagents may come into contact with each other, causing an iodine-forming reaction to occur, producing iodine.
Type:
Grant
Filed:
May 8, 2016
Date of Patent:
February 25, 2020
Assignee:
KCI Licensing, Inc.
Inventors:
Timothy Mark Robinson, Brian Andrews, Christopher Brian Locke
Abstract: The invention pertains to a method for manufacture and use of pesticides or agricultural spray adjuvants that counteracts the effects of hard water cat ions on anionic pesticides when applied in water spray solutions. The disclosed agricultural spray adjuvants include glyphosate compositions comprising a strong mineral acid, such as sulfuric acid, and a polyamine surfactant, such as tallow amine or coco amine.